Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Detection and Treatment of Iron Deficiency in Pregnancy with Respect to Feto-Maternal Outcomes and Cost-Effectiveness: A Population-Based Study
FY 2021-22
Summary
Red blood cells (RBC) circulate in the bloodstream and contain a molecule called hemoglobin (Hb). Hb carries oxygen to body tissues and to the unborn baby of pregnant women. Iron is necessary to make functioning Hb. If a person doesn't have enough iron in the body, they can develop anemia, a condition in which there are not enough RBC and/or the amount of Hb in the cells is too low. Anemia due to low iron is called iron-deficiency anemia (IDA). It is possible to have iron deficiency (ID) before anemia develops.
IDA is the most common cause of anemia in pregnancy. IDA in pregnancy is a global problem accounting for >30% of anemia among pregnant women in Canada and as high as 50% in some countries. We know that IDA is associated with complications during pregnancy. But we don't know if ID itself, before anemia develops, has similar adverse effects in pregnancy. A challenge is that normal levels of tests for ID for the non-pregnant may not be accurate for pregnant women.
The proposed research has three goals:1) to determine which test or combination of tests would work best in pregnant women for diagnosis of ID, 2) to determine whether iron therapy in pregnant women with ID, according to our new definition, but without anemia, improved pregnancy outcomes and 3) to determine which combination of screening, using the new definition, and treatment could yield the best pregnancy outcomes for the least cost. To achieve the first two goals, I will make use of the large store of health information maintained by the Ontario government. To achieve the third goal, I will develop a computer simulation model.
I anticipate that the results of our research could help doctors to identify pregnant women with ID without anemia but could also justify further research studies such as a randomized controlled trial. The results of my simulation study could help health policy makers, in Ontario and in low-income countries such as Nigeria, to decide how to screen and treat ID without anemia.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
457569
Name
Lawani Osaheni L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Detection and Treatment of Iron Deficiency in Pregnancy with Respect to Feto-Maternal Outcomes and Cost-Effectiveness: A Population-Based Study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cost-Effectiveness; Detection; Feto-Maternal Outcomes; Iron Biomarkers; Iron Deficiency; Iron Deficiency Anemia; Iron Treatment; Population-Based Study; Pregnancy
Abstract
Red blood cells (RBC) circulate in the bloodstream and contain a molecule called hemoglobin (Hb). Hb carries oxygen to body tissues and to the unborn baby of pregnant women. Iron is necessary to make functioning Hb. If a person doesn't have enough iron in the body, they can develop anemia, a condition in which there are not enough RBC and/or the amount of Hb in the cells is too low. Anemia due to low iron is called iron-deficiency anemia (IDA). It is possible to have iron deficiency (ID) before anemia develops.
IDA is the most common cause of anemia in pregnancy. IDA in pregnancy is a global problem accounting for >30% of anemia among pregnant women in Canada and as high as 50% in some countries. We know that IDA is associated with complications during pregnancy. But we don't know if ID itself, before anemia develops, has similar adverse effects in pregnancy. A challenge is that normal levels of tests for ID for the non-pregnant may not be accurate for pregnant women.
The proposed research has three goals:1) to determine which test or combination of tests would work best in pregnant women for diagnosis of ID, 2) to determine whether iron therapy in pregnant women with ID, according to our new definition, but without anemia, improved pregnancy outcomes and 3) to determine which combination of screening, using the new definition, and treatment could yield the best pregnancy outcomes for the least cost. To achieve the first two goals, I will make use of the large store of health information maintained by the Ontario government. To achieve the third goal, I will develop a computer simulation model.
I anticipate that the results of our research could help doctors to identify pregnant women with ID without anemia but could also justify further research studies such as a randomized controlled trial. The results of my simulation study could help health policy makers, in Ontario and in low-income countries such as Nigeria, to decide how to screen and treat ID without anemia.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lawani, Osaheni L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~